RecruitingNCT04751448
COLON-MD: Colon Cancer Longitudinal Study
COLON MD: Colon Cancer Longitudinal Study of the Microbial Metabolites and Dietary Factors That Influence Response to Treatment
Sponsor
Baylor Research Institute
Enrollment
11 participants
Start Date
Feb 1, 2021
Study Type
OBSERVATIONAL
Conditions
Summary
The goal of this proposal is to identify how the composition of the gut microbiome and diet interact to impact chemotherapy-induced diarrhea incidence and severity.
Eligibility
Min Age: 18 YearsMax Age: 79 Years
Inclusion Criteria4
- Colon cancer diagnosis
- Age \>18 and \< or equal to 79.
- Ability to perform informed consent
- FOLFOX treatment expected
Exclusion Criteria7
- Not Pregnant
- Does not have Lynch syndrome or FAP diagnosis.
- Inability to perform inform consent
- inability to comply with follow up program
- history of prior colon cancer diagnosis
- previous treatment with antibiotics in the last month.
- previous bowel resection.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04751448
Related Trials
A Trial of RSC-1255 for Treatment of Patients With Advanced Malignancies
NCT046786483 locations
Optimised Post-discharge Care in Older Patients After Surgery for Colon Cancer (ERAS 3.0)
NCT068029912 locations
Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
NCT058069319 locations
Resilience and Equity in Aging, Cancer, and Health (REACH)
NCT046742671 location
A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (mCRC)
NCT0701157614 locations